rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Grace Hyun

Director

Company insider

Files Form 4 as: Director, Veru.

Every Form 4 they filed

In numbers

Trades disclosed
16
Buys
1
Sells
0
Bought
$49K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
13 Nov 2020
Last trade
4 May 2026
Last filed
6 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VERU VeruDirector · Biotechnology · last 4 May 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—97,000 at $0.00filing
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—97,000 at $0.00filing
5 Dec 2025filed 9 Dec 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—6,000 at $0.00filing
1 Oct 2025filed 3 Oct 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—3,000 at $0.00filing
6 May 2025filed 8 May 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
13 Mar 2025filed 14 Mar 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
1 Oct 2024filed 2 Oct 2024VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
6 Aug 2024filed 7 Aug 2024VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
2 Oct 2023filed 17 Nov 2023VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
9 May 2023filed 11 May 2023VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
2 Nov 2022filed 4 Nov 2022VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
29 Mar 2022filed 31 Mar 2022VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
3 Nov 2021filed 5 Nov 2021VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
23 Mar 2021filed 25 Mar 2021VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
10 Mar 2021filed 11 Mar 2021VERU VeruBiotechnologySEC FORM 4 Bought$49K3,500 at $14.09filing
13 Nov 2020filed 17 Nov 2020VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

K. Gary BarnetteChief Scientific Officer · Chief Scientific Officer at Veru, filing Form 4 there in the last year
Michael L. RankowitzDirector · Director at Veru, filing Form 4 there in the last year
Mitchell Shuster SteinerPresident and CEO · President and CEO at Veru, filing Form 4 there in the last year
Michele GrecoChief Admin Officer and CFO · Chief Admin Officer and CFO at Veru, filing Form 4 there in the last year
Harry FischChief Corporate Officer · Chief Corporate Officer at Veru, filing Form 4 there in the last year